Report Detail

Request for Sample of this report

Pharma & Healthcare Global Anticancer Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4673918
    • |
  • 18 February, 2026
    • |
  • Global
    • |
  • 130 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Anticancer Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Anticancer Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anticancer Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Anticancer Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Anticancer Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Anticancer Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anticancer Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anticancer Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche(Genentech), Bayer, Novartis, Pfizer, Amgen, Mabxience, Luoxin Pharmaceutical, Qilu Pharmaceutical, Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.), Fuxing Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Anticancer Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Docetaxel Injection
Paclitaxel Injection
Bevacizumab Injection
Adalimumab Injection
Rituximab Injection
Others
Market segment by Application
Breast Cancer
Stomach Cancer
Ovarian Cancer
Lung Cancer
Testicular Cancer
Cervical Cancer
Endometrial Cancer
Prostate Cancer
Bladder Cancer
Others
Major players covered
Roche(Genentech)
Bayer
Novartis
Pfizer
Amgen
Mabxience
Luoxin Pharmaceutical
Qilu Pharmaceutical
Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.)
Fuxing Medicine
Yuekang Pharmaceutical
Yuheng Pharmaceutical
Hengrui Medicine
Huiyu Pharmaceutical
Changbaishan Pharmaceutical Co., Ltd.
Innovent Biologics (Suzhou) Co., Ltd.
Yifan Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anticancer Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anticancer Injection, with price, sales quantity, revenue, and global market share of Anticancer Injection from 2021 to 2026.
Chapter 3, the Anticancer Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anticancer Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Anticancer Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anticancer Injection.
Chapter 14 and 15, to describe Anticancer Injection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Anticancer Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Docetaxel Injection
    • 1.3.3 Paclitaxel Injection
    • 1.3.4 Bevacizumab Injection
    • 1.3.5 Adalimumab Injection
    • 1.3.6 Rituximab Injection
    • 1.3.7 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Anticancer Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Breast Cancer
    • 1.4.3 Stomach Cancer
    • 1.4.4 Ovarian Cancer
    • 1.4.5 Lung Cancer
    • 1.4.6 Testicular Cancer
    • 1.4.7 Cervical Cancer
    • 1.4.8 Endometrial Cancer
    • 1.4.9 Prostate Cancer
    • 1.4.10 Bladder Cancer
  • 1.5 Global Anticancer Injection Market Size & Forecast
    • 1.5.1 Global Anticancer Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Anticancer Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Anticancer Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Roche(Genentech)
    • 2.1.1 Roche(Genentech) Details
    • 2.1.2 Roche(Genentech) Major Business
    • 2.1.3 Roche(Genentech) Anticancer Injection Product and Services
    • 2.1.4 Roche(Genentech) Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche(Genentech) Recent Developments/Updates
  • 2.2 Bayer
    • 2.2.1 Bayer Details
    • 2.2.2 Bayer Major Business
    • 2.2.3 Bayer Anticancer Injection Product and Services
    • 2.2.4 Bayer Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Bayer Recent Developments/Updates
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Anticancer Injection Product and Services
    • 2.3.4 Novartis Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Novartis Recent Developments/Updates
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Anticancer Injection Product and Services
    • 2.4.4 Pfizer Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Pfizer Recent Developments/Updates
  • 2.5 Amgen
    • 2.5.1 Amgen Details
    • 2.5.2 Amgen Major Business
    • 2.5.3 Amgen Anticancer Injection Product and Services
    • 2.5.4 Amgen Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Amgen Recent Developments/Updates
  • 2.6 Mabxience
    • 2.6.1 Mabxience Details
    • 2.6.2 Mabxience Major Business
    • 2.6.3 Mabxience Anticancer Injection Product and Services
    • 2.6.4 Mabxience Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Mabxience Recent Developments/Updates
  • 2.7 Luoxin Pharmaceutical
    • 2.7.1 Luoxin Pharmaceutical Details
    • 2.7.2 Luoxin Pharmaceutical Major Business
    • 2.7.3 Luoxin Pharmaceutical Anticancer Injection Product and Services
    • 2.7.4 Luoxin Pharmaceutical Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Luoxin Pharmaceutical Recent Developments/Updates
  • 2.8 Qilu Pharmaceutical
    • 2.8.1 Qilu Pharmaceutical Details
    • 2.8.2 Qilu Pharmaceutical Major Business
    • 2.8.3 Qilu Pharmaceutical Anticancer Injection Product and Services
    • 2.8.4 Qilu Pharmaceutical Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.9 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.)
    • 2.9.1 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Details
    • 2.9.2 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Major Business
    • 2.9.3 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anticancer Injection Product and Services
    • 2.9.4 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Recent Developments/Updates
  • 2.10 Fuxing Medicine
    • 2.10.1 Fuxing Medicine Details
    • 2.10.2 Fuxing Medicine Major Business
    • 2.10.3 Fuxing Medicine Anticancer Injection Product and Services
    • 2.10.4 Fuxing Medicine Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Fuxing Medicine Recent Developments/Updates
  • 2.11 Yuekang Pharmaceutical
    • 2.11.1 Yuekang Pharmaceutical Details
    • 2.11.2 Yuekang Pharmaceutical Major Business
    • 2.11.3 Yuekang Pharmaceutical Anticancer Injection Product and Services
    • 2.11.4 Yuekang Pharmaceutical Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Yuekang Pharmaceutical Recent Developments/Updates
  • 2.12 Yuheng Pharmaceutical
    • 2.12.1 Yuheng Pharmaceutical Details
    • 2.12.2 Yuheng Pharmaceutical Major Business
    • 2.12.3 Yuheng Pharmaceutical Anticancer Injection Product and Services
    • 2.12.4 Yuheng Pharmaceutical Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Yuheng Pharmaceutical Recent Developments/Updates
  • 2.13 Hengrui Medicine
    • 2.13.1 Hengrui Medicine Details
    • 2.13.2 Hengrui Medicine Major Business
    • 2.13.3 Hengrui Medicine Anticancer Injection Product and Services
    • 2.13.4 Hengrui Medicine Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Hengrui Medicine Recent Developments/Updates
  • 2.14 Huiyu Pharmaceutical
    • 2.14.1 Huiyu Pharmaceutical Details
    • 2.14.2 Huiyu Pharmaceutical Major Business
    • 2.14.3 Huiyu Pharmaceutical Anticancer Injection Product and Services
    • 2.14.4 Huiyu Pharmaceutical Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Huiyu Pharmaceutical Recent Developments/Updates
  • 2.15 Changbaishan Pharmaceutical Co., Ltd.
    • 2.15.1 Changbaishan Pharmaceutical Co., Ltd. Details
    • 2.15.2 Changbaishan Pharmaceutical Co., Ltd. Major Business
    • 2.15.3 Changbaishan Pharmaceutical Co., Ltd. Anticancer Injection Product and Services
    • 2.15.4 Changbaishan Pharmaceutical Co., Ltd. Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Changbaishan Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.16 Innovent Biologics (Suzhou) Co., Ltd.
    • 2.16.1 Innovent Biologics (Suzhou) Co., Ltd. Details
    • 2.16.2 Innovent Biologics (Suzhou) Co., Ltd. Major Business
    • 2.16.3 Innovent Biologics (Suzhou) Co., Ltd. Anticancer Injection Product and Services
    • 2.16.4 Innovent Biologics (Suzhou) Co., Ltd. Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Innovent Biologics (Suzhou) Co., Ltd. Recent Developments/Updates
  • 2.17 Yifan Pharmaceutical
    • 2.17.1 Yifan Pharmaceutical Details
    • 2.17.2 Yifan Pharmaceutical Major Business
    • 2.17.3 Yifan Pharmaceutical Anticancer Injection Product and Services
    • 2.17.4 Yifan Pharmaceutical Anticancer Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Yifan Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Anticancer Injection by Manufacturer

  • 3.1 Global Anticancer Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Anticancer Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Anticancer Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Anticancer Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Anticancer Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Anticancer Injection Manufacturer Market Share in 2025
  • 3.5 Anticancer Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Anticancer Injection Market: Region Footprint
    • 3.5.2 Anticancer Injection Market: Company Product Type Footprint
    • 3.5.3 Anticancer Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Anticancer Injection Market Size by Region
    • 4.1.1 Global Anticancer Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Anticancer Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Anticancer Injection Average Price by Region (2021-2032)
  • 4.2 North America Anticancer Injection Consumption Value (2021-2032)
  • 4.3 Europe Anticancer Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Anticancer Injection Consumption Value (2021-2032)
  • 4.5 South America Anticancer Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Anticancer Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Anticancer Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Anticancer Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Anticancer Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Anticancer Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Anticancer Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Anticancer Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Anticancer Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Anticancer Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Anticancer Injection Market Size by Country
    • 7.3.1 North America Anticancer Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Anticancer Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Anticancer Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Anticancer Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Anticancer Injection Market Size by Country
    • 8.3.1 Europe Anticancer Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Anticancer Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Anticancer Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Anticancer Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Anticancer Injection Market Size by Region
    • 9.3.1 Asia-Pacific Anticancer Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Anticancer Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Anticancer Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Anticancer Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Anticancer Injection Market Size by Country
    • 10.3.1 South America Anticancer Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Anticancer Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Anticancer Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Anticancer Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Anticancer Injection Market Size by Country
    • 11.3.1 Middle East & Africa Anticancer Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Anticancer Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Anticancer Injection Market Drivers
  • 12.2 Anticancer Injection Market Restraints
  • 12.3 Anticancer Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Anticancer Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Anticancer Injection
  • 13.3 Anticancer Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Anticancer Injection Typical Distributors
  • 14.3 Anticancer Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Anticancer Injection. Industry analysis & Market Report on Anticancer Injection is a syndicated market report, published as Global Anticancer Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Anticancer Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo